Login / Signup

Socioeconomic disparities in clinical trials on Alzheimer's disease: a systematic review.

Marco CanevelliG BrunoC VicoV ZaccariaE LacorteI IavicoliN VanacoreM Cesari
Published in: European journal of neurology (2018)
The research and clinical relevance of SES has mistakenly been overlooked by the vast majority of RCTs on AD. A greater effort should be made to collect and report data on those SES indicators that may significantly affect the clinical manifestations and trajectories of patients with cognitive disturbances.
Keyphrases
  • clinical trial
  • electronic health record
  • depressive symptoms
  • cognitive decline
  • big data
  • affordable care act
  • open label
  • machine learning
  • health insurance